What does Precision BioSciences, Inc. do?

Jun 22 2025 06:29 PM IST
share
Share Via
Precision BioSciences, Inc. is a genome editing company in the Pharmaceuticals & Biotechnology sector, currently reporting no net sales and a net loss of $21 million as of March 2025, with a market cap of $58.30 million. The company has a negative debt-equity ratio and return on equity, with no dividend yield.
Overview:
Precision BioSciences, Inc. is a genome editing company engaged in providing genome engineering technology within the Pharmaceuticals & Biotechnology industry, categorized as a micro-cap.

Financial Snapshot:
Most recent Net Sales: 0 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: -21 Million (Quarterly Results - Mar 2025)
Market cap: USD 58.30 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -1.08
Return on Equity: -83.23%
Price to Book: 1.18

Contact Details:
Address: 302 E Pettigrew St Ste A100, DURHAM NC: 27701-2393
Tel: 1 919 3145512
Website: http://precisionbiosciences.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News